LOPRESSOR Drug Patent Profile
✉ Email this page to a colleague
When do Lopressor patents expire, and when can generic versions of Lopressor launch?
Lopressor is a drug marketed by Novartis and Validus Pharms and is included in four NDAs.
The generic ingredient in LOPRESSOR is hydrochlorothiazide; metoprolol tartrate. There are thirty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.
Summary for LOPRESSOR
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 9 |
Clinical Trials: | 26 |
Patent Applications: | 164 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LOPRESSOR |
What excipients (inactive ingredients) are in LOPRESSOR? | LOPRESSOR excipients list |
DailyMed Link: | LOPRESSOR at DailyMed |
Recent Clinical Trials for LOPRESSOR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Wisconsin, Madison | Phase 2 |
National Center for Advancing Translational Science (NCATS) | Phase 2 |
Corcept Therapeutics | Phase 1 |
Pharmacology for LOPRESSOR
Drug Class | beta-Adrenergic Blocker |
Mechanism of Action | Adrenergic beta-Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for LOPRESSOR
US Patents and Regulatory Information for LOPRESSOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | LOPRESSOR | metoprolol tartrate | INJECTABLE;INJECTION | 018704-001 | Mar 30, 1984 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Validus Pharms | LOPRESSOR | metoprolol tartrate | TABLET;ORAL | 017963-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Novartis | LOPRESSOR | metoprolol fumarate | TABLET, EXTENDED RELEASE;ORAL | 019786-003 | Dec 27, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Validus Pharms | LOPRESSOR HCT | hydrochlorothiazide; metoprolol tartrate | TABLET;ORAL | 018303-001 | Dec 31, 1984 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LOPRESSOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | LOPRESSOR | metoprolol tartrate | INJECTABLE;INJECTION | 018704-001 | Mar 30, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Validus Pharms | LOPRESSOR | metoprolol tartrate | TABLET;ORAL | 017963-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Validus Pharms | LOPRESSOR | metoprolol tartrate | TABLET;ORAL | 017963-002 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | LOPRESSOR | metoprolol tartrate | INJECTABLE;INJECTION | 018704-001 | Mar 30, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LOPRESSOR
See the table below for patents covering LOPRESSOR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Israel | 90019 | Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having improved core membrane adhesion properties | ⤷ Try a Trial |
Malaysia | 7500161 | PHENOXY-HYDROXYPROPYLAMINES AND THEIR PREPARATION | ⤷ Try a Trial |
Denmark | 196189 | ⤷ Try a Trial | |
Ireland | 891316 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |